Quoin Pharmaceuticals
QNRX
2 hedge funds and large institutions have $2.16M invested in Quoin Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
813% more capital invested
Capital invested by funds: $237K → $2.16M (+$1.93M)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.65M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$826K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $1.56M | +$1.65M | +2 | New |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $434K | +$826K | +1 | New |
|
3
Morgan Stanley
New York
| $95K | – | – | – |
|
4
Citigroup
New York
| $62K | – | – | – |
|
|
MIFH
5
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
| $10K | – | – | – |
|
|
APA
6
American Portfolios Advisors
Holbrook,
New York
| $6.38K | – | – | – |
|
QNRX Hedge Fund Activity: Q1 2018 in Review
2 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q1 2018, worth a combined $2.16M — up 813% from $237K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new QNRX positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.65M.
- 2 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q1 2018, up from 0 in Q4 2017.
- Funds reported $2.16M of Quoin Pharmaceuticals stock for Q1 2018, up 813% quarter-over-quarter.
- 2 funds opened new Quoin Pharmaceuticals positions in Q1 2018 and 0 closed out, a net change of +2 holders.
- The largest Quoin Pharmaceuticals buyer in Q1 2018 was Sabby Management, an estimated $1.65M added.
Based on aggregated 13F filings for Q1 2018.